DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Virtual Event

2021年3月22日 (月) 午前 9:50 - 2021年3月24日 (水) 午後 2:30

(Eastern Standard Time)

Horsham, PA 19044

Medical Affairs and Scientific Communications Forum

Session 8 Track 3: Why Science Needs More Diversity in Clinical Trials

Session Chair(s)

Lori  Mouser, PharmD

Lori Mouser, PharmD

Senior Director, Global Head of Oncology Scientific Engagement and Congresses

Daiichi Sankyo Inc., Switzerland

This session will focus on the scientific rationale for driving for more diversity in clinical trial programs. Ideas for how to ensure more diverse populations of patients have access to clinical trials as an option to treatment will be shared. Presenters will explore the role field teams can play in engaging with clinical trial sites.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify examples of where race or gender differences lead to divergent clinical outcomes.
  • Discuss reasons why broadening the diversity of patients across clinical trial programs is needed.
  • Describe how field medical teams can support clinical trial sites in patient screening and enrollment.

Speaker(s)

Danielle  Day, PhD

Speaker

Danielle Day, PhD

Sobi, United States

Senior Medical Director, Immunology, Rare Disease

Nicole  Richie, PhD

Speaker

Nicole Richie, PhD

Genentech, United States

Global Head Health Equity and Population Science, Clinical Development

Bethsheba  Johnson

Speaker

Bethsheba Johnson

Gilead Sciences, Inc, United States

Senior Director, HIV Prevention Field Director Western US

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。